"Glyurenorm": ntuziaka maka ojiji, n'ezie na ogbo

Insulin dabere-arịa ọrịa shuga mellitus ma ọ bụ ọrịa shuga nke abụọ ụdị a na-akpọ a metabolic ọrịa. Ọ e ji adịghị ala ala hyperglycemia, nke na-amalite n'ihi ọrịa na insulin mmekọrịta anụ ahụ na mkpụrụ ndụ.

Mgbaàmà nke ọrịa a bụ nkụ na akpịrị ịkpọ nkụ ke inua, oké urination, muscle adịghị ike, anụ itching, ọjọọ zazhivlyaemost ọnyá na ibu oké ibu. Maka ọgwụgwọ nke ụdị 2 ọrịa shuga na-eji ọgwụ ọjọọ, "Glyurenorm". Ntuziaka maka ojiji, analogs, Njirimara na udi nke si ọgwụ ọjọọ na-ọkọnọ n'okpuru.

The mejupụtara nke ọgwụ, ya nkọwa, nkwakọ, udi

Na ihe n'ụdị na-emepụta ọgwụ "Glyurenorm"? Ntuziaka maka ojiji na-akọ na a owuwu bụ dị n'ụdị nke na-acha ọcha mbadamba na-eji ire ụtọ gburugburu udi, na Valium na beveled n'ọnụ, na kanyere "57C" na ụlọ ọrụ logo.

The isi akụrụngwa nke ọgwụ a na-ewere gliquidone. Ọzọkwa ya mejupụtara ndị mịrị amị ọka starch, lactose monohydrate, ọka starch na soluble magnesium stearate (ọzọ ogige).

Na ire nke ọgwụ ọjọọ, "Glyurenorm" (mbadamba) na-ọnọ na ọnya Ukwu nke 10 mbak, nke na-packaged ke Ukwu nke kaadiboodu.

The ọgwụ

Gịnị bụ ọgwụ "Glyurenorm"? Ntuziaka maka ojiji na-akọ na a hypoglycemic gị n'ụlọnga, sulfonylurea (abụọ emana). Ọ na-aduak naanị maka onu ochichi.

Weere a ọgwụ nwere vnepankreaticheskim na pancreatic mmetụta. Ọ-akpali secretion nke insulin na potentiates glucose-onye ogbugbo ụzọ nke ya guzobere.

Nlele na laabu anụmanụ gosiri na ọgwụ "Glyurenorm" ntụziaka nke a na-dị na a igbe mere nke katọn, ike nke na mbenata insulin na-eguzogide na adipose anụ ahụ na ọrịa na-imeju. Na nke a emee site mmalite postreceptor usoro na na-onye ogbugbo ya insulin, nakwa dị ka ụba ihe nnabata thereto.

Hypoglycemic mmetụta mgbe dosing amalite mgbe 65-95 nkeji. Banyere kacha mmetụta nke ọgwụ, ya emee mgbe banyere 2-3 awa na-ewe ihe 8-10 awa.

kinetic Njirimara

Ojiji "Glyurenorma" ntụziaka na-enye na iji ihe a otu dose nke ọgwụ (15-30 mg) na-eme ka ya ngwa ngwa zuru ezu absorption si eriri afọ tract (banyere 80-95%). Elu ya ịta mgbe ọ esịmde a 2 hour.

Active mgwa nke a agwọ ọrịa nwere nnukwu mmekọrita na plasma-edozi.

Ọ dịghị data na puru nke na-agafe gliquidone ma ọ bụ ya emepụta site na Plasenta ma ọ bụ ọbara-ụbụrụ mgbochi e. Ọzọkwa, ọ dịghị ihe ọmụma banyere ihe penetration gliquidone na mmiri ara nne.

Ebe metabolism "Glyurenorm" ọgwụ ọjọọ? Ntuziaka maka ojiji na-ekwu na ahuta gị n'ụlọnga na-metabolized na imeju site demethylation na hydroxylation.

Isi akụkụ gliquidone nkwekọrịta ewepụtara site na eriri afọ. The ọkara ndụ oge nke ọgwụ bụ 1-2 awa.

Ndị agadi na katatụrụ ọrịa kinetic parameters "Glyurenorma" yiri.

Dị ka ndị ọkachamara, nke a pụtara na metabolism na-agbanwebeghị na ọrịa na hepatic insufficiency. Ọ kwesịkwara kwuru na ọrịa na mkpọchị akụrụ ọrụ ọgwụ adịghị akpọkọtara.

na-agba akaebe

N'okpuru ihe ọnọdụ ndị kasị dị irè iji ọgwụ na-akpa àgwà "Glyurenorm"? Ntuziaka maka ojiji, reviews na-ekwu na-egosi na ya iji bụ ọrịa shuga-arịa ọrịa shuga nke abụọ ụdị ndị agadi na katatụrụ (na adịghị ike nke ndị na-eri).

Ukpan na-enweta ọgwụ

Na nke ikpe na-contraindicated idepụta mkpụrụ ọgwụ "Glyurenorm"? Ntuziaka maka ojiji na-egosi ndị na-esonụ contraindications nke ọgwụ:

• intermittent porphyria nnukwu;
• -arịa ọrịa shuga mellitus mbụ ụdị;
• hepatic ọdịda, oké;
• ọrịa acidosis, precoma, ketoacidosis na amaghị onwe;
• oge mgbe resection nke pancreatic cancer;
• Dị otú ahụ dị ụkọ butere n'aka ọdịdị nke ọrịa dị ka galactosemia, lactose ekweghị ibe nọrọ, enweghị lactase na glucose-galactose malabsorption;
• nnukwu ọnọdụ onye ọrịa (e.g., oké njọ usoro ịwa ahụ, na-efe efe ọrịa);
• n'oge ime;
• obere afo (n'ihi enweghị data na nchekwa na nrụpụta ọrụ nke ọgwụ a na ọgbọ);
• ara;
• hypersensitivity ka sulfonamides.

Nlezianya kwadebe n'ikuku

Na nlezianya tụlee agwọ ọrịa kenyere:

• feverish syndrome;
• enweghị glucose-6-phosphate dehydrogenase;
• ọrịa nke thyroid gland (mebiri nke ya ọrụ);
• aṅụrụma.

Drug "Glyurenorm": ntuziaka maka ojiji

"Glyurenorm" mkpụrụ ọgwụ kenyere naanị n'ime. Na ha n'ikuku ka ọ dị mkpa ime na niile na-atụ aro nke dọkịta banyere onunu ogwu na ọgwụ na nri. A machibidoro iwu ịkwụsị ịṅụ ọgwụ enweghị mbụ izu a ọkachamara.

Mbụ dose akuko n'aka bụ 0,5 mbadamba (i.e., 15 mg) ke akpa nri ụtụtụ. The ọgwụ kwesịrị iwere na mmalite nke nri. Mgbe amachibidoro ya Skip nri.

Ọ bụrụ na ị na-eji 1/2 Erere adịghị akpata mma, mgbe oge na a dọkịta dịkwuo onunu ogwu nwayọọ nwayọọ. Na a kwa ụbọchị dose nke "Glyurenorma" ọ dịghị ihe karịrị 2 mbadamba, ya nwere ike iwere otu ugbo n'oge nri ụtụtụ.

Ọ bụrụ na dọkịta na-edepụta a elu onunu ogwu nke ọgwụ, mgbe kacha mma mmetụta ha ga-ekewa 2 ma ọ bụ 3 doses.

Higher doses ruo 4 mbadamba kwa ụbọchị na-emekarị bụghị dịkwuo ha arụmọrụ. Ya mere, na-na nkà mmụta ọgwụ "Glyurenorm" ka nke a ukwuu ego na-adịghị na-atụ aro.

Na ndị mmadụ na mkpọchị ọrụ nke akụrụ onunu ogwu ukpụhọde a chọrọ.

Na-ewere ọgwụ ọjọọ karịa 75 mg na ọrịa na mkpọchị imeju ọrụ na-achọ mgbe nile nlekota site dọkịta.

na "Glyurenormom" ndidi nwere ike Ọzọkwa kenyere "metformin" na ezughi oke ọgwụgwọ mmetụta.

ikpe nke ovadozu

N'ikuku nke elu doses nke sulfonylurea nkwekọrịta akpatakarị hypoglycemia. Ke adianade do, ihe ovadozu nke ngwá ọrụ a nwere ike ime ka ndị na-esonụ mgbaàmà: sweating, tachycardia, ogwe, agụụ, isi ọwụwa, palpitations, tremor, ehighi ura, erughị ala, bịara ikiri ọhụụ na-ekwu okwu, ọnwụ nke nsụhọ.

Ọ bụrụ na ihe ịrịba ama nke hypoglycemia ga-glucose ma ọ bụ ihe oriri ọgaranya carbohydrates.

mmetụta

Ugbu a, ị maara, ihe na-kenyere ndị dị otú ahụ a ọgwụ dị ka "Glyurenorm". Ntuziaka maka ojiji nke ọgwụ nwekwara e tụlere n'elu.

Dị ka okwu nke ọrịa, na a n'ikuku nke ego nwere ike ịbụ:

• thrombocytopenia, rịaworo, agranulocytosis;
• paresthesia, hypoglycemia, dizziness;
• leukopenia, isi ọwụwa, gafere, iro ụra;
• ulo n'ọgba aghara, ike ọgwụgwụ, hypotension;
• obi odida, akọrọ ọnụ, Stevens-Johnson syndrome;
• ebelata agụụ, photosensitivity mmeghachi omume, ọgbụgbọ, ọkụ ọkụ;
• aṅụ, vomiting, obi mgbu, cholestasis;
• ntachi, itching, afọ ọsịsa, erughị ala na afo.

ọgwụ interactions

Mgbe concomitantly na gliquidone "Allopurinol", Ace inhibitors, antifungals, analgesics, coumarin nkwekọrịta, NSAIDs na ndị ọzọ na hypoglycemic mmetụta pụrụ adịkwu mbụ.

"Rifampicin" barbiturates na "Phenytoin" ala hypoglycemic mmetụta "Glyurenorma".

kpọmkwem na-atụ aro

Hypoglycemic mmadụ maka onu ochichi ga dochie ọgwụ nri.

Ndị na-arịa ọrịa shuga niile dọkịta nkwanye ga-nditịm hụrụ.

Ọ bụrụ na ihe ịrịba ama nke hypoglycemia kwesịrị ozugbo iri nri na e dere sugar.

Mmega ahụ nwere ike welie hypoglycemic mmetụta nke ọgwụ ahụ.

Nyere na gbasara akụrụ excretion gliquidone site ubé, anya agwọ ọrịa nwere ike n'enweghị eji ọrịa na gbasara akụrụ impairment na nephropathy nke-arịa ọrịa shuga.

N'oge Clinical ọmụmụ ọ hụrụ na ojiji nke ọgwụ n'okpuru echiche na-adịghị aka dịkwuo ọrịa arọ ahụ maka 30 ọnwa. Ọzọkwa, mgbe e kwuru ọnụ arọ ahụ site 1-2 n'arọ.

Analogs na reviews

Site analogues nke ọgwụ "Glyurenorm" na-agụnye ndị na-esonụ n'aka: "Gliklada", "Amiks", "Glianov", "Glayri", "Glibetik".

Nyocha nke ugbu nkà mmụta ọgwụ nwere ike izute ndị kasị dị iche iche. Dị ka akụkọ na-eji ọkụ, a ọgwụ dị irè na inweta onye ọ bụla. Otú ọ dị, ọ ga-ahụ kwuru ọtụtụ ndị ọrịa bụ nnọọ nchegbu banyere ndepụta mmetụta nke a n'ụlọnga. Ọ bụ ezie na dọkịta na-ekwu na ha ime nnọọ adịkarịghị na naanị na ụfọdụ.